NASDAQ:HCWB | Free Cash Flow | HCW Biologics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.58M
2025-12-31-$3.36M$0.00-$3.36M-466.54%
2025-03-31-$3.51M$0.00-$3.51M
2024-12-31-$2.83M$113,412.00-$2.95M
2024-03-31-$3.6M$129,709.00-$3.73M
2023-12-31-$3.89M$3.72M-$7.61M
2023-03-31-$3.64M$300,385.00-$3.94M
2022-12-31-$3.79M$68,687.00-$3.86M
2022-03-31-$1.59M$23,554.00-$1.62M
2021-12-31-$3.38M$19,852.00-$3.4M
2021-03-31-$1.49M$23,279.00-$1.51M
2020-12-31-$3.54M$36,391.00-$3.57M-173.41%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$13.39M$0.00-$13.39M
2024-12-31-$14.23M$261,617.00-$14.49M
2023-12-31-$22.51M$6.2M-$28.72M
2022-12-31-$10.39M$10.28M-$20.66M
2021-12-31-$10.98M$47,263.00-$11.02M
2020-12-31-$10.43M$186,682.00-$10.62M